Palivizumab injection is used to prevent serious lung infection in children and babies caused by respiratory syncytial virus ...

Palivizumab (Synagis; MedImmune/Abbott) is a humanized murine monoclonal antibody against the RSV fusion protein that prevents the spread of virus to the lower respiratory tract 2. It was approved ...

Palivizumab was a monthly injection that helped protect babies and young children from RSV (respiratory syncytial virus), and was proven to reduce hospitalisation rates for at-risk babies.